Ben Baldanza, Who Brought No-Frills Flying to Spirit Airlines, Dies at 62
He introduced ticket prices that couldn’t be beat, but asked fliers to pay extra for nearly everything, including water, ...
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
Expects to complete healthy volunteer Phase 1 clinical study of ATH-1105 by year end and begin dosing ALS patients in ...
Neuroscience News2h
Pathway Identified for Early Intervention in ALS Progression
Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...
Key pathway leading to neurodegeneration in early stages of ALS identified
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
BioPharma Dive4h
Athira exploring strategic alternatives after Alzheimer’s failure
On the heels of its most advanced medicine flunking a key study, the drugmaker is looking at the different paths it could ...
Armed robbery in Revesby6h
Crucial ALS Neurodegeneration Pathway Uncovered
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years ...
ALS News Today8h
I AM ALS unveils new campaign aimed at supporting caregivers
This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...
gna13h
UG, Google, and UCL develop speech recognition technology for Ghanaian languages
The University of Ghana (UG), in collaboration with Google Research Africa and the University College of London’s (UCL) ...
Investing19h
4 Biotech Stocks With AI, Machine Learning Prowess
Neurosense Therapeutics (NASDAQ:NRSN) is developing novel treatments for neurodegenerative diseases like amyotrophic lateral ...